N-myc downstream-regulated gene 2 inhibits human cholangiocarcinoma progression and is regulated by leukemia inhibitory factor/MicroRNA-181c negative feedback pathway

miRNA-181 regulates embryo implantation in mice through targeting leukemia inhibitory factor

(2015) Bo Chu et al.   Journal of Molecular Cell Biology

Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation

(2015) Stuart Duncan Morton et al.   Oncotarget

MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment

(2015) Maria Pisarello et al.   Journal of Clinical Medicine

LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway

(2015) Xiaoyan Li et al.   Oncotarget

The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway

(2015) Jiabei Wang et al.   Oncotarget

MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2

(2014) Ping Huang et al.   TUMOR BIOLOGY

MicroRNA Profiling Reveals Unique miRNA Signatures in IGF-1 Treated Embryonic Striatal Stem Cell Fate Decisions in Striatal NeurogenesisIn Vitro

(2014) Soumya Pati et al.   Biomed Research International

Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells

(2013) Jean-Charles Neel et al.   CELLULAR SIGNALLING

Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma

(2013) Laurent Sulpice et al.   HEPATOLOGY

miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor

(2013) Martin Pichler et al.   JOURNAL OF CLINICAL PATHOLOGY

The Iron Chelators Dp44mT and DFO Inhibit TGF-β-induced Epithelial-Mesenchymal Transition via Up-Regulation of N-Myc Downstream-regulated Gene 1 (NDRG1)

(2012) Zhiqiang Chen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Reduction in miR-141 is Induced by Leukemia Inhibitory Factor and Inhibits Proliferation in Choriocarcinoma Cell Line JEG-3

(2011) Diana M. Morales-Prieto et al.   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650

(2011) Li Feng et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression

(2011) Jin Zheng et al.   BMC CANCER

miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma

(2011) Cheng-Chieh Yang et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Dynamic Modulation of Thymic MicroRNAs in Response to Stress

(2011) Serkan Belkaya et al.   PLoS One

NDRG2 Ameliorates Hepatic Fibrosis by Inhibiting the TGF-β1/Smad Pathway and Altering the MMP2/TIMP2 Ratio in Rats

(2011) Jiandong Yang et al.   PLoS One

TGF-β Increases Glioma-Initiating Cell Self-Renewal through the Induction of LIF in Human Glioblastoma

(2009) Silvia Peñuelas et al.   CANCER CELL

Suppression of NF- B activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells

(2009) A. Kim et al.   CARCINOGENESIS

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

(2009) Junfang Ji et al.   HEPATOLOGY

Wnt-5a-CKIα Signaling Promotes β-Catenin/E-Cadherin Complex Formation and Intercellular Adhesion in Human Breast Epithelial Cells

(2009) Catharina Medrek et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

miR-21 and 221 upregulation and miR-181b downregulation in human grade II–IV astrocytic tumors

(2009) Alfredo Conti et al.   JOURNAL OF NEURO-ONCOLOGY

TGFβ-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3

(2009) B Wang et al.   ONCOGENE

Functional and Clinical Evidence for NDRG2 as a Candidate Suppressor of Liver Cancer Metastasis

(2008) D. C. Lee et al.   CANCER RESEARCH

Frequent promoter hypermethylation and transcriptional downregulation of theNDRG2gene at 14q11.2 in primary glioblastoma

(2008) Martin Tepel et al.   INTERNATIONAL JOURNAL OF CANCER